European ScreeningPort (ESP) is a public private partnership which offers fee-for-service small molecule screening to academic institutions.

Our goal is to transform the exciting new science, taking place at the benchtops of Europe’s academic laboratories, into chemical tools and high quality assets of explicit value to potential major partners in the Pharmaceutical industry and - ultimately to patients.

What we can do for you:

Do you have a promising target, a disease relevant model system or an innovative idea and are searching for means to develop these further? Are you interested in starting a small molecule screening campaign to identify validated hits as starting points for medicinal chemistry optimisation? Our cost-effective, scalable Drug Discovery Services for the European biomedical research community can help you to achieve this goal. Our services include:

• support in evaluating funding opportunities and complementation of our customers project management capacities
• expertise in assay development covering multiple target classes and therapeutic areas
• access to high quality compound libraries and state-of-the art high throughput screening facilities
• direct access to pharmaceutical-scale medicinal chemistry and bioinformatics infrastructure and processes